中国中药2024年度溢利净额同比下降90%-100%

中金在线
17 Jan

据在香港注册并上市的 中国 中药 控股有限公司1月15日发布的“内幕消息盈利预警”:截至到2024年12月31日、该公司年度未经审核 综合 管理账目初步评估,预计该集团2024年度溢利净额同比下降90%-100%;经调整溢利净额同比下降50%-60%。在该“内幕消息盈利预警”中,中国中药还将原因总结为三个:一、集采降价、市场竞争加剧及药材成本偏高等多重因素影响配方颗粒业务销售规模及盈利水平;二、在...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10